Thomas Leggett - Chief Financial Officer at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
STOK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Leggett since 11/27/2024

Holdings reported by Thomas Leggett for Stoke Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 59K $488K $8.27 Mar 20, 2025 Direct Common Stock
Stock Option (Right to Buy) 396K May 15, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 89K Mar 20, 2025 Direct Common Stock

Transactions reported by Thomas Leggett for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.